Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 9.73%. However, over the last six months, the performance has been weaker by 37.42%. The price of BMY decreased -3.76% over the last 30 days. And in the last five days, it has fallen by -4.11%.
Bristol-Myers Squibb Co experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $61.08 on 11/11/24, while the lowest price for the same period was registered at $39.35 on 07/05/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of BMY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Bristol-Myers Squibb Co’s current trading price is -7.83% away from its 52-week high, while its distance from the 52-week low is 43.07%. The stock’s price range during this period has varied between$39.35 and $61.08. The Bristol-Myers Squibb Co’s shares, which operate in the Healthcare, saw a trading volume of around 7.37 million for the day, a figure considerably lower than their average daily volume of 11.09 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Bristol-Myers Squibb Co (BMY) has experienced a quarterly rise of 13.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 113.17B and boasts a workforce of 34100 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 52.57, with a change in price of +11.08. Similarly, Bristol-Myers Squibb Co recorded 11,516,641 in trading volume during the last 100 days, posting a change of +24.48%.
BMY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 3.00. Similarly, the long-term debt-to-equity ratio is also 2.93.
BMY Stock Stochastic Average
As of today, Bristol-Myers Squibb Co’s raw stochastic average for the last 50 days stands at 51.59%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 23.23%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 15.27% and 17.70%, respectively.
